Cyclosporin (CsA) is currently the main immunosuppressive agent used in organ transplantation with considerable improvement in graft survival. Oral CsA solution is highly lipophilic, and its bioavailability may be reduced in cystic fibrosis (CF) heart-lung transplant recipients with pancreatic, gas
β¦ LIBER β¦
Combined lung and liver transplantation in a girl with cystic fibrosis
β Scribed by A. Andrew Zimmerman; Todd K. Howard; Charles B. Huddleston
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- French
- Weight
- 411 KB
- Volume
- 46
- Category
- Article
- ISSN
- 1496-8975
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cyclosporin pharmacokinetics in heart-lu
β
V. T. Tsang; A. Johnston; F. Heritier; N. Leaver; M. E. Hodson; M. Yacoub
π
Article
π
1994
π
Springer
π
English
β 529 KB
Successful liver transplantation using t
β
Abdul Rahman Aljebreen; Marc DeschΔnes; Les Lilly; Peter Metrakos
π
Article
π
2003
π
John Wiley and Sons
π
English
β 151 KB
The role of liver transplantation in cys
β
Maureen M. Jonas
π
Article
π
2005
π
John Wiley and Sons
π
English
β 46 KB
π 1 views
Cystic fibrosis patients with and withou
β
Amy B. Goldstein; Lawrence S. Goldstein; Mary K. Perl; Marcus T. Haug; Alejandro
π
Article
π
2000
π
John Wiley and Sons
π
English
β 71 KB
π 2 views
FEV1 as a guide to lung transplant refer
β
Walter Robinson; David A. Waltz
π
Article
π
2000
π
John Wiley and Sons
π
English
β 50 KB
π 1 views
Liver transplantation in patients with c
β
Manuel Mendizabal; K. Rajender Reddy; James Cassuto; Kim M. Olthoff; Thomas W. F
π
Article
π
2011
π
John Wiley and Sons
π
English
β 206 KB
π 1 views
The improved life expectancy of patients with cystic fibrosis (CF) has led to a change in the impact of liver disease on the prognosis of this population. Liver transplantation has emerged as the procedure of choice for patients with CF and features of hepatic decompensation and for intractable vari